ALL

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ALL, Hodgkin Lymphoma, Cancer Trial in Memphis (Transcranial photobiomodulation (tPBM) - Mobile System)

Not yet recruiting
  • ALL
  • +3 more
  • Transcranial photobiomodulation (tPBM) - Mobile System
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Sep 21, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

ACL Injury, ALL Trial in Otwock (ACL reconstruction, ALL anatomic, ALL tenodesis)

Recruiting
  • ACL Injury
  • ALL
  • ACL reconstruction
  • +2 more
  • Otwock, Mazowieckie, Poland
    Department of Orthopaedics and Traumatology, Centre of Postgradu
Jul 13, 2022

Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy

Recruiting
  • DLBCL
  • +8 more
  • Cardiac MRI
  • Bonn, NRW, Germany
    University Hospital Bonn
Jun 11, 2022

AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

Recruiting
  • AML
  • +8 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 13, 2022

ALL Trial in Spain (Prednisone, Vincristine, Daunorubicin)

Active, not recruiting
  • ALL
  • Badalona, Spain
  • +9 more
Feb 17, 2022

AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)

Recruiting
  • AML - Acute Myeloid Leukemia
  • +5 more
  • T-allo10
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

AML, Advanced MDS, ALL Trial in Chicago, New York (OTS167IV)

Terminated
  • AML
  • +4 more
  • Chicago, Illinois
  • +1 more
Nov 15, 2021

ACL, Anterior Curciate Ligament, Anterolateral Ligament Trial in Lyon (Radiography)

Recruiting
  • ACL
  • +4 more
  • Radiography
  • Lyon, France
    Hopital privé Jean Mermoz
Nov 9, 2021

B-precursor Acute Lymphoblastic Leukemia, ALL, GNR-084 Trial in Moscow, Saint Petersburg (GNR-084, 0.01 ng/kg, GNR-084, 0.1

Recruiting
  • B-precursor Acute Lymphoblastic Leukemia
  • +2 more
  • GNR-084, 0.01 ng/kg
  • +5 more
  • Moscow, Russian Federation
  • +2 more
Oct 25, 2021

B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL Trial in Boston (Venetoclax, Dexamethasone, Inotuzumab Ozogamicin)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 19, 2021

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

Acute Lymphoblastic Leukemia, ALL, Childhood, ALL Trial in Chicago (Ruxolitinib, Cyclophosphamide, Cytarabine)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
    University of Chicago Medical Center
Sep 14, 2021

AML, ALL, MDS Trial in Germany (Peripheral blood stem cells)

Recruiting
  • AML
  • +2 more
  • Peripheral blood stem cells
  • Bonn, Germany
  • +8 more
Aug 25, 2021

Family History in a Singaporean Healthy Population

Recruiting
  • All
  • MeTree
  • Singapore, Singapore
    National Heart Centre of Singapore
Aug 17, 2021

Optical Genome Mapping in Hematological Malignancies

Recruiting
  • MDS
  • +2 more
    • Brest, France
    • +3 more
    Aug 16, 2021

    ALL Trial in Chicago (IOHEXOL)

    Completed
    • ALL
    • Chicago, Illinois
      Ann & Robert H. Lurie Children's Hosptial of Chicago
    Jul 26, 2021

    ALL, B Cell Lymphoma, Leukemia Trial run by the NCI (Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR))

    Completed
    • ALL
    • +4 more
    • Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 14, 2020

    ALL, Burkitt's Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (Rapamycin + high dose etoposide and cytarabine)

    Terminated
    • ALL
    • +3 more
    • Rapamycin + high dose etoposide and cytarabine
    • Philadelphia, Pennsylvania
      University of Pennsylvania Abramson Cancer Center
    Apr 15, 2020

    All Trial in United States

    Active, not recruiting
    • All
      • Mountain View, California
      • +4 more
      Dec 17, 2019

      Hodgkin Lymphoma, Lymphocytic Leukemia, Mixed Cell Leukemia Trial run by the NCI (Stem cell transplantation)

      Completed
      • Hodgkin Lymphoma
      • +8 more
      • Stem cell transplantation
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Dec 13, 2019

      AML, ALL, Undifferentiated Leukemia Trial in Boston (Abatacept)

      Completed
      • AML
      • +11 more
      • Boston, Massachusetts
        Boston Children's Hospital
      Oct 31, 2019

      Breast Cancer, ALL, Lung Cancer Trial in Belgium (Implementation of a care pathway)

      Recruiting
      • Breast Cancer
      • +5 more
      • Implementation of a care pathway
      • Turnhout, Antwerpen, Belgium
      • +3 more
      Apr 15, 2019

      Relapsed/Refractory AML, Relapsed/Refractory ALL, Secondary AML/MDS Trial in Canada, United States (Plerixafor Dose Escalation)

      Completed
      • Relapsed/Refractory AML
      • +5 more
      • Plerixafor Dose Escalation
      • Phoenix, Arizona
      • +8 more
      Sep 5, 2018

      Methotrexate Induced Gastrointestinal Intolerance in Juvenile

      Completed
      • Juvenile Idiopathic Arthritis
      • ALL
        • (no location specified)
        Aug 16, 2018